id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
DEA-2023-0028-0001,DEA,DEA-2023-0028,Expansion of Induction of Buprenorphine via Telemedicine Encounter,Proposed Rule,,2023-03-01T05:00:00Z,2023,3,2023-03-01T05:00:00Z,2023-04-01T03:59:59Z,2023-04-01T23:39:12Z,2023-04217,0,0,09000064857323db